Jemperli Royalty Monetization Agreement was Anaptysbio’s largest revenue line in fiscal 2024, bringing in $47.40M of $91.30M (52%).
| Type Of Arrangement | FY 2015 | FY 2017 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Milestone Agreements | $60.00M | $5.00M | — | $40.00M | |||
| Collaborative Research & Development Agreement | — | — | — | — | |||
| Jemperli Royalty Monetization Agreement | — | $2.30M | $13.80M | $47.40M | |||
| Royalty Agreement | $3.20M | — | — | — | |||
| Zejula Royalty Monetization Agreement | — | $1.40M | — | $3.90M | |||
| Zejula Revenue | — | $1.60M | $3.40M | — | |||
| Total | $63.20M | $10.30M | $17.20M | $91.30M |
Anaptysbio brought in $91.30M from its three revenue lines in fiscal 2024, the year ended December 31, 2024. Anaptysbio regrouped these revenue lines after fiscal 2023, so the total does not compare directly with that year's $17.20M. Jemperli Royalty Monetization Agreement was the largest at $47.40M (51.9%), ahead of Milestone Agreements at $40.00M (43.8%) and Zejula Royalty Monetization Agreement at $3.90M (4.3%).
Anaptysbio began breaking out Jemperli Royalty Monetization Agreement in fiscal 2022 and Zejula Royalty Monetization Agreement in fiscal 2022. Anaptysbio stopped reporting Zejula Revenue ($3.40M in fiscal 2023) and Royalty Agreement ($3.20M in fiscal 2021) as separate revenue lines.
Anaptysbio (ANAB) reports its revenue by type of arrangement. In fiscal 2024, Jemperli Royalty Monetization Agreement was its largest revenue line, bringing in $47.40M (51.9% of the total), followed by Milestone Agreements at $40.00M (43.8%).
Jemperli Royalty Monetization Agreement was Anaptysbio's largest revenue line in fiscal 2024, bringing in $47.40M, or 51.9% of the $91.30M total across its three revenue lines.
Every figure comes from Anaptysbio's annual financial filings, as reported. Each line keeps the name Anaptysbio gives it, and years follow its fiscal calendar.
Anaptysbio's revenue by type of arrangement goes back to fiscal 2015, with figures through fiscal 2024. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.